The relative distribution of CYP1A1, CYP1A2 and CYP1B1 product; and 2-OH-PhIP, the mutagenic potential of which between human tissues appears to differ. While CYP1A2 was is unknown. Metabolite identity was confirmed by coshown to be primarily expressed in the liver (10), CYP1A1 and elution with authentic standards and synchronous fluores-CYP1B1 were shown to be primarily expressed in extrahepatic cence spectroscopy. The identity of the 2-OH-PhIP standard tissues (1,5,11). Specifically, CYP1B1 mRNA was found to was additionally confirmed by mass spectrometry. Kinetic be constitutively expressed in most of the adult tissues which studies of the formation of N 2 -OH-PhIP, 4Ј-OH-PhIP and were tested, including kidney, prostate, uterus, mammary and 2-OH-PhIP by CYP1B1 indicated apparent K m values colon and in several fetal tissues, including heart and kidney of 5.7 ⍨ 1.3, 2.2 ⍨ 0.5 and 1.3 ⍨ 0.2 µM, respectively.
Introduction causes a significant increase in the incidence of colon cancer in male rats and mammary tumors in female rats (19, 20) , as The cytochrome P450 (CYP*) enzyme superfamily metabolizes well as lymphomas in mice (21). PhIP is bioavailable in human a wide variety of xenobiotics to reactive intermediates which populations as demonstrated by its detection in human urine are implicated in toxicity and carcinogenesis. Cytochrome from healthy subjects eating normal diets and charbroiled P4501B1 (CYP1B1) was recently identified in humans (1) and beef (22,23). rodents (2) (3) (4) as the newest member of the dioxin-inducible Like many other environmental carcinogens, PhIP requires CYP1 family which includes CYP1A1 and CYP1A2. The metabolic activation to exert toxic effects. Previous studies indicate that PhIP is converted to two primary products: 2- (4Ј-OH-PhIP), the former being highly mutagenic, and the N2-OH-PhIP, 2-hydroxy-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine; 2-latter being non-mutagenic, in both bacterial and mammalian nitro-PhIP, 2-nitro-1-methyl-6-phenylimidazo [4,5-b] pyridine; 2-OH-PhIP, 2-genotoxicity assays (18, (24) (25) (26) . These metabolites may subhydroxy-1-methyl-6-phenylimidazo [4,5-b] which lack CYP1B1 did not metabolize PhIP ( Figure 1C , CЈ).
CYP1B1 expression constructs
While 4Ј-OH-PhIP and N 2 -OH-PhIP are well characterized CYP1B1 cDNA constructs (CYP1B1 ∆0 and ∆3) were generated to express products of CYP1A1 and CYP1A2, the production of 2-OHthe human CYP1B1 protein in yeast, as previously described (6). CYP1B1∆0
PhIP has been reported only twice. For this reason, several was constructed to express the entire deduced amino acid sequence. In different methods were used to confirm the identity of the CYP1B1∆3, the first three coding residues following the initial methionine, amino acid residues 2-4, were deleted. This corresponds to the amino acid putative 2-OH-PhIP peak. The 2-OH-PhIP standard produced sequence reported for purified rat CYP1B1, which lacks the first four amino from 2-nitro-PhIP was isolated by HPLC. The positive ion acids of the deduced human amino acid sequence (33) . fast atom bombardment mass spectra of this 2-OH-PhIP
Microsomes were isolated (6), and total P450 content and yeast NADPH standard showed an ion at 226 (M ϩ H), consistent with the cytochrome P450 reductase activity were determined as described (34) . Microsomal protein content was estimated using the BioRad (Hercules, CA) identity of 2-OH-PhIP (data not shown; (24,27)). By HPLC, protein assay. P450 yields were~10-fold higher in CYP1B1∆3 when compared this 2-OH-PhIP standard co-eluted with the putative 2-OHto CYP1B1∆0, while the levels of endogenous yeast reductase were similar (6).
PhIP peak produced by CYP1B1 ( Figure 1 ).
Microsomal assays
PhIP metabolites produced by CYP1B1 were isolated by For determination of PhIP metabolism, incubation mixtures typically consisted HPLC and analysed by SFS at a wavelength difference of of 0.5 mg/ml microsomal protein, 100 mM sodium phosphate buffer, pH 7.4, 55 nm. These metabolites showed distinct fluorescence max-5 mM MgCl 2 , 1 mM NADP ϩ , 15 mM glucose-6-phosphate, 1 U/ml glucoseima: 2-OH-PhIP (309 nm), N 2 -OH-PhIP (312 nm), PhIP 6-phosphate dehydrogenase, and varying amounts of PhIP as substrate.
(316 nm), and 4Ј-OH-PhIP (320 nm) (Figure 2 ). These fluorReaction mixtures were pre-incubated for 5 min at 37°C prior to initiation with NADP ϩ , and terminated by adding one volume of ice-cold methanol.
escence maxima are identical to those seen for standard
The precipitated proteins were removed by centrifugation at 4°C. Samples preparations of PhIP and PhIP metabolite standards, including were stored at -80°C, prior to analysis by HPLC within 48 h after collection. the 2-OH-PhIP standard produced in this study (data not CYP1B1∆3 microsomes were used to analyse the kinetics of PhIP metabolshown).
ism using eight different concentrations of PhIP as substrate. The velocity of PhIP metabolite production was assayed as a function of PhIP metabolite production was also evaluated using CYP1B1∆0 microsomes. Kinetic parameters were estimated using Enzfitter software (Biosoft, Camtime and microsomal protein concentration to determine the bridge, MA). In some assays, NADP ϩ was excluded to confirm that metabolite conditions under which metabolite production was linear, prior production by CYP1B1∆3 and CYP1B1∆0 microsomes was NADPH-dependto performing kinetics experiments. The production of each of ent. Similarly, microsomes containing the yeast vector only were tested metabolite was linear up to a 20 min incubation time and to confirm that microsomes which lack the CYP1B1 construct do not metabolize PhIP.
up to 0.6 mg/ml microsomal protein. Subsequent kinetics 20 µM substrate data point, where its production declined. N 2 -OH-PhIP (C) Metabolic products of PhIP incubated with microsomes which lack the values for 0.313 and 0.625 µM were below the limit of detection and not human CYP1B1 enzyme (vector control).
plotted. *Duplicate samples.
While the rate of formation of 4Ј-OH-PhIP and N 2 -OH-PhIP experiments were conducted using a 15-min incubation time and 0.5 mg/ml microsomal protein.
appeared to reach saturation at concentrations of PhIP above 10 µM, the formation of 2-OH-PhIP appeared to saturate at a The kinetics of PhIP metabolite production were determined at seven different concentrations of PhIP, ranging from 0.313 to concentration of PhIP below 10 µM. The values of apparent K m and V max derived from these 20 µM, in triplicate experiments using CYP1B1∆3 (Figure 3) . studies of the PhIP metabolizing enzymes CYP1A1 and In relation to the metabolism of PhIP, CYP1B1 appears to c Velocity determined from triplicate assays using 10 µM PhIP and 0.5 mg/ resemble both CYP1A1 and CYP1A2 in that both 4Ј-OH-PhIP ml CYP1B1∆3 microsomes.
and N 2 -OH-PhIP are produced. Although 4Ј-OH-PhIP has been d Velocity determined from triplicate assays using 10 µM PhIP and 1.0 mg/ ml CYP1B1∆0 microsomes.
shown to be non-genotoxic, N 2 -OH-PhIP, and several of its e Significantly different from corresponding ∆3 value, P Ͻ 0.005.
conjugated products are mutagenic in both mammalian and f Significantly different from corresponding ∆3 value, P Ͻ 0.0005.
bacterial assays and are believed to be a potential source of PhIP-related cancers. While CYP1A2 is found primarily in curves are shown in Table I . Apparent K m values range between the liver, CYP1B1 mRNA is constitutively expressed in a 1.3 and 5.7 µM, and are highest for N 2 -OH-PhIP, followed by variety of human tissues, including the colon, small intestine, 4Ј-OH-PhIP and 2-OH-PhIP. As determined using CYP1B1∆3, breast and several fetal tissues (1,5). Thus, it is plausible that V max values range between 0.04 and 0.48 nmol/min/nmol P450, CYP1B1 may contribute to extrahepatic PhIP metabolism and and are highest for 4Ј-OH-PhIP, followed by N 2 -OH-PhIP and PhIP-related disease.
2-OH-PhIP. Recent studies in this laboratory indicated that
While 4Ј-OH-PhIP and N 2 -OH-PhIP are commonly reported endogenous NADPH P450 reductase levels are limiting in PhIP metabolites, much less has been published concerning microsomes expressing CYP1B1∆3, but not CYP1B1∆0 (6).
the formation of 2-OH-PhIP. 2-OH-PhIP has been identified Thus, while CYP1B1∆3 microsomes, because of their high in rat urine (39) and as a product of rat liver microsomes (27) , P450 content, are useful for identifying metabolic products, but not in other metabolism studies, including those with CYP1B1∆0 microsomes, with their lower P450 content and human liver microsomes (37). 2-OH-PhIP may not have been non-limiting reductase levels, are likely to provide more identified in human samples from previous studies because it accurate estimates of turnover numbers for PhIP is produced in relatively low amounts and is more easily hydroxylations. For this reason, enzyme velocity was evaluated detected by fluorescence than the more commonly used in triplicate assays using CYP1B1∆0 microsomes at a single absorbance. substrate concentration, 10 µM (Table I) . This substrate con-
The K m values for PhIP metabolite production were fairly centration was chosen for optimal production of all three similar for the three products. The V max values for the three metabolites because 2-OH-PhIP production declined above products varied; at saturating levels of substrate, the formation 10 µM. At 10 µM, the enzyme velocity for the CYP1B1∆0 of 4Ј-OH-PhIP was favored~2-fold and Ͼ10-fold over N 2 -construct was~2-fold higher than that of CYP1B1∆3 for the OH-PhIP and 2-OH-PhIP, respectively. Because the reductase production of 4ЈOH-PhIP (P Ͻ 0.005) and N 2 -OH-PhIP (P Ͻ levels were limiting in the microsomes containing CYP1B1∆3, 0.0005), but was not elevated for 2-OH-PhIP production.
but not in the microsomes of CYP1B1∆0, CYP1B1∆0 microsomes were used to determine more accurate estimates of Discussion turnover numbers for PhIP hydroxylations. The enzyme velocity values for 4Ј-OH-PhIP and N 2 -OH-PhIP formation Numerous studies in recent years have shown that CYP1A1 and CYP1A2 metabolize common environmental carcinogens obtained from microsomes of CYP1B1∆0 were~2-fold higher than those obtained using microsomes of CYP1B1∆3. This to reactive intermediates which may increase cancer risk in susceptible individuals. Given that there are strong similarities increase is consistent with previous studies using these constructs, where differences in enzyme velocity were shown to between the protein sequence of CYP1 family enzymes, it seemed likely that the newest member of this group, CYP1B1, be due, at least in part, to the limiting levels of reductase in CYP1B1∆3 (5,6). would also play an important role in carcinogen metabolism and, possibly, susceptibility to cancer. The studies reported in It is unclear why 2-OH-PhIP levels did not differ between constructs as greatly as the other PhIP metabolites; the lack this paper indicate that PhIP, a putative colon and breast carcinogen in humans, is a metabolic substrate of the human of a difference may reflect the mechanism of 2-OH-PhIP formation, which is not known. There are at least two possible CYP1B1 protein.
Our results indicate that PhIP is metabolized by the mechanisms for 2-OH-PhIP formation. 2-OH-PhIP may be formed by a secondary hydroxylation of N 2 -OH-PhIP at N-2, human CYP1B1 gene to yield three products: 4Ј-OH-PhIP, N 2 -OH-PhIP and 2-OH-PhIP. At saturating levels of substrate, followed by a spontaneous loss of the nitro group by reaction with water (27) . Alternatively, CYP1B1 may enzymatically 4Ј-OH-PhIP formation is favored~2-fold and Ͼ10-fold over N 2 -OH-PhIP and 2-OH-PhIP formation, respectively. Previous deaminate PhIP and the resulting carbocation may react with 
